trending Market Intelligence /marketintelligence/en/news-insights/trending/AsIMmOCjHb9izVXPGDHp_A2 content esgSubNav
In This List

Achillion Pharmaceuticals' chief medical officer resigns

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Achillion Pharmaceuticals' chief medical officer resigns

David Apelian resigned as executive vice president and chief medical officer of Achillion Pharmaceuticals Inc., effective Dec. 28.

Apelian resigned to pursue another professional opportunity

The company has started searching for a new chief medical officer.